tulip: trastuzumab duocarmazine improved pfs in pre-treated her2 breast cancer
Published 3 years ago • 125 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
2:49
trastuzumab duocarmazine for her2 locally advanced or metastatic cancer
-
2:15
treatment strategies for her2 metastatic breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
2:34
esmo 2021 breast cancer highlights: tulip and keynote-355
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
1:39
treatment for her2 metastatic breast cancer
-
1:03:59
selecting and sequencing of her2-targeting therapies in her2-positive metastatic breast cancer
-
1:11:23
her2 positive breast cancer management
-
58:08
metastatic breast cancer update
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
5:29
adding lapatinib to adjuvant trastuzumab doesn't improve outcomes in her2-positive breast cancer
-
1:47
her2climb-05: tucatinib trastuzumab and pertuzumab as maintenance therapy for her2 metastatic bc
-
7:44
treatment options for her2 breast cancer: a comprehensive guide
-
5:55
decision-making in metastatic her2 breast cancer
-
1:29
poziotinib for her2-positive metastatic breast cancer
-
3:20
dr. hurvitz on eliminating anthracyclines in her2 breast cancer treatment
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
-
4:31
study of atezolizumab with pertuzumab and trastuzumab in her2- positive metastatic breast cancer
-
5:50
her2climb: investigating tucatinib with capecitabine and trastuzumab in her2-positive metastatic...
-
4:16
adjuvant treatment for stage i her2 breast cancer